How to Present Healthcare Company Culture and Team Stability as a Real Asset
How to Present Healthcare Company Culture and Team Stability as a Real Asset Key Takeaways Why Buyers Care About Culture Healthcare buyers are not only buying EBITDA. They are buying continuity, leadership trust, and the likelihood that performance will hold after closing. That is why cultural diligence matters in a sale process, especially when it […]
Read More
How to Avoid Buyer Retrades: The Healthcare Company CEO’s Prevention Plan
How to Avoid Buyer Retrades: The Healthcare Company CEO’s Prevention Plan Key Takeaways Why Buyer Retrades Happen in Healthcare Deals A retrade happens when a buyer comes back after the LOI and asks for a lower price, tighter terms, or added protections. In healthcare, this usually follows diligence findings tied to billing, compliance, staffing, or […]
Read More
From Deal Execution to Enterprise Value Creation: The New Firm Mandate
From Deal Execution to Enterprise Value Creation: The New Firm Mandate Key Takeaways The Healthcare M&A Landscape Is Undergoing a Structural Shift For years, healthcare mergers and acquisitions have followed a familiar formula: grow revenue, stabilize EBITDA, hire a healthcare business broker, and take the asset to market. If the numbers looked attractive, a deal […]
Read More